舒尼替尼-话题@MedSci

#舒尼替尼#

1篇内容 | 1707人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2186216, encodeId=37922186216fb, content=<a href='/topic/show?id=3cc88658264' target=_blank style='color:#2F92EE;'>#舒尼替尼#</a> <a href='/topic/show?id=5dd28335eea' target=_blank style='color:#2F92EE;'>#胃肠道间质瘤#</a> <a href='/topic/show?id=02982402298' target=_blank style='color:#2F92EE;'>#二线治疗#</a> <a href='/topic/show?id=594853956a' target=_blank style='color:#2F92EE;'>#ctDNA#</a> <a href='/topic/show?id=7c6e10858461' target=_blank style='color:#2F92EE;'>#瑞派替尼#</a>, objectTitle=Nat Med：胃肠道间质瘤二线治疗选瑞派替尼or舒尼替尼？血液ctDNA揭晓答案, objectType=article, longId=812546, objectId=c1938125467e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=c1938125467e, replyNumber=0, likeNumber=88, createdTime=2024-02-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=c1938125467e, moduleTitle=Nat Med：胃肠道间质瘤二线治疗选瑞派替尼or舒尼替尼？血液ctDNA揭晓答案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1938125467e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184488, encodeId=7676218448832, content=<a href='/topic/show?id=3cc88658264' target=_blank style='color:#2F92EE;'>#舒尼替尼#</a> <a href='/topic/show?id=01a536491b9' target=_blank style='color:#2F92EE;'>#卡博替尼#</a> <a href='/topic/show?id=fc2be734870' target=_blank style='color:#2F92EE;'>#纳武利尤单抗#</a> <a href='/topic/show?id=c193110640f1' target=_blank style='color:#2F92EE;'>#ASCO GU 2024#</a>, objectTitle=ASCO GU 2024：纳武利尤单抗/卡博替尼治疗晚期肾癌优于舒尼替尼（CheckMate-9ER 研究）, objectType=article, longId=811384, objectId=440881138441, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240128/1706443016945_8624274.png, objectUrl=/article/show_article.do?id=440881138441, replyNumber=0, likeNumber=0, createdTime=2024-01-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=440881138441, moduleTitle=ASCO GU 2024：纳武利尤单抗/卡博替尼治疗晚期肾癌优于舒尼替尼（CheckMate-9ER 研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=440881138441)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241273, encodeId=4a0112412e3a2, content=<a href='/topic/show?id=5dd28335eea' target=_blank style='color:#2F92EE;'>#胃肠道间质瘤#</a>与<a href='/topic/show?id=3cc88658264' target=_blank style='color:#2F92EE;'>#舒尼替尼#</a>, objectTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, objectType=article, longId=735738, objectId=bcb3e35738dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220812/1660287288774_2110107.JPG, objectUrl=/article/show_article.do?id=bcb3e35738dd, replyNumber=0, likeNumber=145, createdTime=2022-08-27, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcb3e35738dd, moduleTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcb3e35738dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

舒尼替尼

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#舒尼替尼# #胃肠道间质瘤# #二线治疗# #ctDNA# #瑞派替尼#

Nat Med：胃肠道间质瘤二线治疗选瑞派替尼or舒尼替尼？血液ctDNA揭晓答案

2024-02-06发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#舒尼替尼# #卡博替尼# #纳武利尤单抗# #ASCO GU 2024#

ASCO GU 2024：纳武利尤单抗/卡博替尼治疗晚期肾癌优于舒尼替尼（CheckMate-9ER 研究）

2024-01-28发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#胃肠道间质瘤#与#舒尼替尼#

J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤

2022-08-27

科室
- - 订阅+
  - 更多科室
工具
服务